Thrombosis and Haemostasis, Inhaltsverzeichnis Thromb Haemost 1988; 59(02): 129-132DOI: 10.1055/s-0038-1642740 Review Article Schattauer GmbH Stuttgart Confusion Over the Therapeutic Range for Monitoring Oral Anticoagulant Therapy in North America J Hirsh 1 The Department of Medicine, McMaster University, Hamilton, Ontario, Canada , M Levine 1 The Department of Medicine, McMaster University, Hamilton, Ontario, Canada › Institutsangaben Artikel empfehlen Abstract als PDF herunterladen Artikel einzeln kaufen Keywords KeywordsWarfarin - Therapeutic range - Standardization - Low dose PDF (241 kb) Referenzen References 1 ACCP/NHLBI National Conference on Antithrombotic Therapy. Chest. 89. Suppl 02/1986 2 Hirsh J. Is the dose of warfarin prescribed by American Physicians unnecessarily high. Arch Intern Med 1987; 147: 769-771 3 Zucker S, Cathey MH, Sox PJ, Hallec EC. Standardisation of laboratory tests for controlling anticoagulant therapy. Am J Clin Pathol 1970; 53: 348-354 4 Poller L. Progress in standardisation in anticoagulant control. Hematol Rev 1987; 1: 225-241 5 Kirkwood TB L. Calibration of Reference Thromboplastins and Standardisation of the Prothrombin Time Ratio. Thromb Haemostas 1983; 49: 238-244 6 Loeliger EA. ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control. Thromb Haemostas 1985; 54: 155-156 7 Quick AJ. The prothrombin time in haemophilia and in obstructive jaundice. J Biol Chem 1935; 109: 73-74 8 Poller L, Taberner DA. Dosage and control of oral anticoagulants: An international survey. Br J Haematol 1982; 51: 479-485 9 Wright IS, Beck DF, Marple CD. Myocardial infarction and its treatment with anticoagulants: Summary of findings in 1031 cases. Lancet 1954; 1: 92-95 10 Wright IS. Recent developments in antithrombotic therapy. Ann Intern Med 1969; 71 (04) 823-831 11 Hull R, Hirsh J, Jay R. et al. Different intensities of anticoagulation in the long term treatment of proximal venous thrombosis. N Engl J Med 1982; 307: 1676-1681 12 Hull R, Delmore T, Genton E. et al. Warfarin sodium versus low dose heparin in the long term treatment of venous thromboembolism. N Engl J Med 1979; 301: 855-858 13 Hull R, Delmore T, Carter C. et al. Adjusted subcutaneous heparin versus warfarin sodium in the long term treatment of venous thrombosis. N Engl J Med 1982; 306: 189-194 14 Taberner DA, Poller L, Burslem RW, Jones JB. Oral anticoagulants controlled by the British Comparative thromboplastin versus low dose heparin in prophylaxis of deep venous thrombosis. Br Med J 1978; 1: 272-274 15 Francis CW, Marder VJ, McCollister EC. et al. Two-step warfarin therapy. JAMA 1983; 249: 374-378 16 Drapkin A, Merskey C. Anticoagulant therapy after acute myocardial infarction. JAMA 1972; 222: 541-548 17 Medical Research Council. Assessment of short term anticoagulant administration after cardiac infarction. Br Med J 1969; 1: 335-342 18 Veterans Administration. Anticoagulants in acute myocardial infarction. JAMA 1973; 225: 724-729 19 Bjerkelund CJ, Orning OM. The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation. Am J Cardiol 1969; 23: 208-216 20 Gogstad GO, Wadt J, Smith P. et al. Utility of a Modified Calibration Model for reliable Conversion of Thromboplastin Times to International Normalized Ratios. Thromb Haemostas 1986; 56: 178-182